Form 8-K - Current report:
SEC Accession No. 0001213900-25-004220
Filing Date
2025-01-16
Accepted
2025-01-16 16:30:08
Documents
13
Period of Report
2025-01-16
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227953-8k_renalytix.htm   iXBRL 8-K 25003
  Complete submission text file 0001213900-25-004220.txt   193938

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rnlxy-20250116.xsd EX-101.SCH 3021
3 XBRL LABEL FILE rnlxy-20250116_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rnlxy-20250116_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0227953-8k_renalytix_htm.xml XML 3406
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 25535991
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)